Scinai Immunotherapeutics Ltd.
SCNINASDAQHealthcare● Active
$0.41
$-0.00(-1.14%)
Market Cap$536143
P/E Ratio—
52W High$3.48
52W Low$0.367
Scinai Immunotherapeutics Ltd.（SCNI）· 损益表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · SCNI · 截至 2026-06-09
财务报表
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $1.31M | $0.66M | $0.00M | $0.00M | $0.00M |
| Cost of Revenue | $3.96M | $1.24M | $0.51M | $0.56M | $0.75M |
| Gross Profit | ($2.65M) | ($0.58M) | ($0.51M) | ($0.56M) | ($0.75M) |
| Gross Margin %(computed) | -202.29% | -88.15% | — | — | — |
| Operating Expenses | |||||
| R&D Expenses | $2.37M | $5.53M | $5.21M | $5.76M | $3.25M |
| G&A Expenses | $0.00M | $0.00M | $0.00M | $0.00M | $7.72M |
| Total Operating Expenses | $4.89M | $8.06M | $9.71M | $11.06M | $10.86M |
| Operating Income | ($7.54M) | ($8.64M) | ($9.71M) | ($11.06M) | ($10.87M) |
| Operating Margin %(computed) | -575.29% | — | — | — | — |
| Interest Income | $0.02M | $0.10M | $0.12M | $8.10M | $0.00M |
| Interest Expense | $0.36M | $1.44M | $0.01M | $5.05M | $3.36M |
| Income Before Tax | ($8.31M) | $4.80M | ($6.50M) | ($5.80M) | ($8.21M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | $0.00M | $0.00M |
| Net Income | ($8.31M) | $4.80M | ($6.50M) | ($5.80M) | ($8.21M) |
| Net Margin %(computed) | -633.64% | 728.88% | — | — | — |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-3.60 | $6.00 | $-16.80 | $-30.80 | $-80.00 |
| Wtd Avg Shares | 2.33M | 0.81M | 0.39M | 0.19M | 0.10M |
| EBITDA | ($6.53M) | ($6.99M) | ($9.19M) | ($10.50M) | ($10.39M) |
| EBITDA Margin %(computed) | -497.86% | — | — | — | — |
数据来源：Financial Modeling Prep · 最后更新：2026-06-09 · USD · M
深入了解Scinai Immunotherapeutics Ltd.
关于Scinai Immunotherapeutics Ltd.（SCNI）损益表
Scinai Immunotherapeutics Ltd.（SCNI）损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年，SCNI实现营收$0.00B，毛利润($0.00B)（毛利率-202.29%），净利润($0.01B)（净利率-633.64%）。
常见问题
SCNI · 4 问Scinai Immunotherapeutics Ltd.（SCNI）2025财年营收为$0.00B，同比up99.2%。
SCNI revenueSCNI salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09